Replies to post #104129 on Biotech Values

[dewophile]

trial on mC 3Q2011 or later

i thought i heard they estimate a one quarter delay from initial projection of end Q3 2010-Q4 2010, so sounds like Q42010-Q12011

[ThomasS]

MNTA: If Copaxone has been fully characterized, it is a reasonable assumption that Lovenox was fully characterized.
Any clues on whether MNTA/Sandoz would launch "at-risk" if FDA approves mCopaxone?